Arcellx (ACLX) Other Non-Current Assets (2021 - 2025)

Arcellx (ACLX) recorded quarterly Other Non-Current Assets of $3.0 million in Q4 2025, up 814.29% quarter-over-quarter from $329000.0 in Q3 2025, and up 179.29% on a YoY basis from $1.1 million in Q4 2024.

Arcellx (ACLX) Other Non-Current Assets (2021 - 2025) Analysis & Trends

Arcellx's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $3.0 million for Q4 2025.

  • In Q4 2025, Other Non-Current Assets rose 179.29% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (up 179.29% YoY), while the FY2025 annual figure was $3.0 million, up 179.29% from the prior year.
  • Other Non-Current Assets was $3.0 million for Q4 2025 at Arcellx, up from $329000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $9.4 million in Q4 2023 to a low of $199000.0 in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $2.6 million across 5 years, with a median of $2.5 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets jumped 1156.78% in 2023, then sank 88.49% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $3.2 million in 2021, then decreased by 21.15% to $2.5 million in 2022, then jumped by 274.09% to $9.4 million in 2023, then tumbled by 88.49% to $1.1 million in 2024, then surged by 179.29% to $3.0 million in 2025.
  • The last three Other Non-Current Assets figures came in at $3.0 million (Q4 2025), $329000.0 (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - 3.01 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.01 Mn
Sep 30, 2025 329,000.00
Jun 30, 2025 2.42 Mn
Mar 31, 2025 2.42 Mn
Dec 31, 2024 1.08 Mn
Sep 30, 2024 1.33 Mn
Jun 30, 2024 1.22 Mn
Mar 31, 2024 2.42 Mn
Dec 31, 2023 9.36 Mn
Sep 30, 2023 4.93 Mn
Jun 30, 2023 2.50 Mn
Mar 31, 2023 2.50 Mn
Dec 31, 2022 2.50 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.50 Mn
Mar 31, 2022 199,000.00
Dec 31, 2021 3.17 Mn